We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Pfizer Inc (PFE) Com Stk USD0.05 (CDI)

Sell:$52.72 Buy:$52.73 Change: $1.19 (2.31%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.19 (2.31%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.19 (2.31%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.

Contact details

235 E 42ND ST
United States
+1 (212) 5732323

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$303.38 billion
Shares in issue:
5.61 billion
New York Stock Exchange
United States
US dollar

Key personnel

  • Albert Bourla
    Chairman of the Board, Chief Executive Officer
  • Angela Hwang
    Group President, Pfizer Biopharmaceuticals Group
  • Payal Sahni
    Chief Human Resource Officer, Executive Vice President
  • Lidia Fonseca
    Executive Vice President, Chief Technology Officer and Digital Officer
  • Rady Johnson
    Executive Vice President, Chief Compliance, Quality and Risk Officer
  • Douglas Lankler
    Executive Vice President, General Counsel
  • William Carapezzi
    Executive Vice President - Global Business Services and Transformation
  • Alexander Mackenzie
    Executive Vice President, Chief Development Officer
  • Aamir Malik
    Executive Vice President, Chief Business Innovation Officer
  • Mike Mcdermott
    Executive Vice President, Chief Global Supply Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.